Cannabis and the related hemp plant have been used by many cultures throughout human history for medicinal and industrial benefits. For many years, research into the benefits of cannabis was hampered by widespread prohibition due to the hallucinogenic effect of one of its components, Δ9 tetrahydrocannabinol (THC). Only recently have researchers been able to demonstrate the surprising efficacy and safety of the use of cannabis, and low THC hemp derived products.
As knowledge of the benefits of cannabis and low THC hemp has expanded, so has demand. Coupled with a worldwide wave of changes in regulation, the market is estimated to grow to $31 billion dollars within 3 years (Brightfield Report cited in Financial Post).
Cannabis and hemp contain over 110 different compounds known as cannabinoids, as well as essential oils called terpenes. Products containing cannabinoids and terpenes have broad therapeutic and lifestyle applications through their interactions with the body’s natural endocannabinoid system.
Plant-based cannabinoids assist the human endocannabinoid system in its role of maintaining balance, or homeostasis throughout the body. Cannabinoid based therapies have been shown to assist with a wide range of symptoms for pain, anxiety, metabolic and inflammatory disorders.